mazindol has been researched along with Central Nervous System Origin Vertigo in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enzi, G | 1 |
| Baritussio, A | 1 |
| Marchiori, E | 1 |
| Crepaldi, G | 1 |
1 trial available for mazindol and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
Topics: Adolescent; Adult; Anxiety; Diet, Reducing; Drug Evaluation; Glucose Tolerance Test; Humans; Indoles | 1976 |